Publications

467 publications

Enter search criteria
Fill in keyword(s) to narrow your search.
Period
You can select a specific type of a publication you are looking for, such as press releases or speeches
Sort by:
  1. Alitretinoin (Toctino) for the indication preoperative treatment of severe chronic hand eczema

    The applicant claims that treatment with alitretinoin is a cost-effective intervention for the treatment of severe chronic hand ...

    Report | 17-12-2012

  2. Crisantaspase (Erwinase) for the indications acute lymphatic leukaemia & lymphoblastic non-Hodgkin lymphoma

    Asparaginase is an important part of treatment of ALL and lymphoblastic non-Hodgkin lymphoma. The use of asparaginase has been ...

    Report | 17-12-2012

  3. Aclidinium (Eklira Genuair ) for the indication ‘COPD’

    For the treatment of COPD, the therapeutic value of aclidinium is equal to that of tiotropium. This report is a summary of ...

    Report | 26-11-2012

  4. Testosterone undecanoate (Nebido) for the indication ‘hypogonadism’

    When treating hypogonadism, the therapeutic value of i.m. testosterone undecanoate is equal to that of the other testosterone ...

    Report | 26-11-2012

  5. Prucalopride (Resolor) for symptomatic treatment of chronic constipation in women who obtain insufficient relief with laxatives

    However, the use of prucalopride is registered for women in whom laxatives fail to provide adequate relief. It is not clear ...

    Report | 26-11-2012

  6. Glycopyrronium (Seebri) for the indication ‘COPD’

    For the treatment of COPD is the therapeutic value of glycopyrronium comparable with that of tiotropium. This report is a summary ...

    Report | 26-11-2012

  7. Zygoma implants in cases of atrophic edentulous maxilla

    In this outcome of assessment, CVZ examines whether using zygoma implants to treat atrophic edentulous maxilla (upper jaw) can be ...

    Report | 12-11-2012

  8. Efficacy of interspinous implants

    The treatment of spinal stenosis with interspinous implants does not comply with the established medical science and medical ...

    Report | 30-10-2012

  9. Rivaroxaban (Xarelto) for prevention of CVA and systemic embolism in patients with non-valvular atrium fibrillation

    In comparison with vitamin K antagonists, rivaroxaban has a therapeutic added value and its therapeutic value is equal to that of ...

    Report | 26-10-2012

  10. The Preventative Consultation

    In principle, a case whereby an individual patient takes the initiative and approaches his G.P. with a question regarding his ...

    Report | 26-10-2012